These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 3365670)

  • 1. Essential thrombocythemia. Clinical characteristics and course of 61 cases.
    Hehlmann R; Jahn M; Baumann B; Köpcke W
    Cancer; 1988 Jun; 61(12):2487-96. PubMed ID: 3365670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical characterization of essential thrombocythemia in comparison with other myeloproliferative diseases and reactive thrombocytoses].
    Jahn M; Zönnchen B; Köpcke W; Hehlmann R
    Klin Wochenschr; 1988 Mar; 66(5):190-8. PubMed ID: 3163063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombocyte function in essential thrombocythemia and reactive thrombocytosis].
    Baumann B; Hillmar I; Hehlmann R
    Klin Wochenschr; 1988 Mar; 66(5):199-207. PubMed ID: 2834604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and differential criteria of essential thrombocythemia and reactive thrombocytosis.
    Kutti J; Wadenvik H
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():41-5. PubMed ID: 8951771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myeloproliferative diseases with an elevated platelet count (in excess of 1,000,000/microliter): a clinicopathological study on 46 patients with special emphasis on primary (essential) thrombocythemia.
    Thiele J; Moedder B; Kremer B; Zankovich R; Fischer R
    Hematol Pathol; 1987; 1(4):227-37. PubMed ID: 3504437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial essential thrombocythemia.
    Fernandez-Robles E; Vermylen C; Martiat P; Ninane J; Cornu G
    Pediatr Hematol Oncol; 1990; 7(4):373-6. PubMed ID: 2268537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome].
    Brière J
    Bull Acad Natl Med; 2007 Mar; 191(3):535-48. PubMed ID: 18072652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential thrombocythemia in young adults.
    McIntyre KJ; Hoagland HC; Silverstein MN; Petitt RM
    Mayo Clin Proc; 1991 Feb; 66(2):149-54. PubMed ID: 1994135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential thrombocythemias. Clinical evolutionary and biological data.
    Bellucci S; Janvier M; Tobelem G; Flandrin G; Charpak Y; Berger R; Boiron M
    Cancer; 1986 Dec; 58(11):2440-7. PubMed ID: 3768838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Megakaryocytic pseudomyelosis with severe thrombocytosis].
    Krug K; Rohrberg R; Wessel H
    Z Gesamte Inn Med; 1981 Oct; 36(19):734-7. PubMed ID: 6171109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of essential thrombocythemia at platelet counts between 400 and 600x10(9)/L. Gruppo Italiano Malattie Mieloproliferative Croniche(GIMMC).
    Sacchi S; Vinci G; Gugliotta L; Rupoli S; Gargantini L; Martinelli V; Baravelli S; Lazzarino M; Finazzi G
    Haematologica; 2000 May; 85(5):492-5. PubMed ID: 10800165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probable essential thrombocythemia in a dog.
    Hopper PE; Mandell CP; Turrel JM; Jain NC; Tablin F; Zinkl JG
    J Vet Intern Med; 1989; 3(2):79-85. PubMed ID: 2715960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis--a critical evaluation of clinical and histomorphological data.
    Thiele J; Zankovich R; Steinberg T; Kremer B; Fischer R; Diehl V
    Acta Haematol; 1989; 81(4):192-202. PubMed ID: 2474228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Megakaryocytic myelosis--clinical aspects, morphology and platelet function].
    Hochhaus A; Höche D; Mindner K; Ostermann G; Meyer M
    Klin Wochenschr; 1989 Jan; 67(2):51-9. PubMed ID: 2921844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential thrombocythemia: a hypercoagulable state.
    Hunter Mellado RF; Oppenheimer Catalá J; Vázquez Medina J
    Bol Asoc Med P R; 1991 Oct; 83(10):436-9. PubMed ID: 1789889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles.
    Petrides PE; Siegel F
    Blood Cells Mol Dis; 2006; 36(3):379-84. PubMed ID: 16563815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Megakaryocytic myelosis: clinical and morphological features (author's transl)].
    Prechtel K; Beil E; Kronseder A
    Dtsch Med Wochenschr; 1977 Jun; 102(23):853-7. PubMed ID: 266986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Megakaryopoietic cytokine levels in patients with essential thrombocythemia and their relationship with clinical and biochemical features].
    Marta RF; Goette NP; Molinas FC
    Medicina (B Aires); 2006; 66(6):540-6. PubMed ID: 17240625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value of megakaryocytic and erythroid colony formation and platelet function tests on the risk of thromboembolic and bleeding complications in essential thrombocythaemia.
    Niittyvuopio R; Juvonen E; Kekomäki R; Oksanen K; Anttila P; Ruutu T
    Eur J Haematol; 2004 Apr; 72(4):245-51. PubMed ID: 15089761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The assessment of platelet function in patients with essential thrombocythemia].
    Treliński J; Tybura M; Chojnowski K
    Pol Merkur Lekarski; 2008 Jul; 25(145):19-22. PubMed ID: 18839608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.